Ribavirin had been available on a named patient basis prior to licensing. Linked evidence DHSC0006176_072 - Briefing on Hepatitis C Payment Scheme - 24 May 1999 Chronology Information Date: 24 May 1999 Chapter/issue Access to Treatment